These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 26159590)

  • 41. FDG-PET-based differential uptake volume histograms: a possible approach towards definition of biological target volumes.
    Devic S; Mohammed H; Tomic N; Aldelaijan S; De Blois F; Seuntjens J; Lehnert S; Faria S
    Br J Radiol; 2016 Jun; 89(1062):20150388. PubMed ID: 27007269
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human adipose tissue glucose uptake determined using [(18)F]-fluoro-deoxy-glucose ([(18)F]FDG) and PET in combination with microdialysis.
    Virtanen KA; Peltoniemi P; Marjamäki P; Asola M; Strindberg L; Parkkola R; Huupponen R; Knuuti J; Lönnroth P; Nuutila P
    Diabetologia; 2001 Dec; 44(12):2171-9. PubMed ID: 11793018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Measurement of skeletal muscle glucose utilization by dynamic 18F-FDG PET without arterial blood sampling.
    Yokoyama I; Inoue Y; Moritan T; Ohtomo K; Nagai R
    Nucl Med Commun; 2005 Jan; 26(1):31-7. PubMed ID: 15604945
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 18F-FDG PET findings in frontotemporal dementia: an SPM analysis of 29 patients.
    Jeong Y; Cho SS; Park JM; Kang SJ; Lee JS; Kang E; Na DL; Kim SE
    J Nucl Med; 2005 Feb; 46(2):233-9. PubMed ID: 15695781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cerebral arterial inflow assessment with 18F-FDG PET: methodology and feasibility.
    Benathan-Tordjmann J; Bailly P; Meyer ME; Daouk J
    Comput Methods Programs Biomed; 2014 Oct; 116(3):177-83. PubMed ID: 25015567
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preclinical dynamic 18F-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis.
    Røe K; Aleksandersen TB; Kristian A; Nilsen LB; Seierstad T; Qu H; Ree AH; Olsen DR; Malinen E
    Acta Oncol; 2010 Oct; 49(7):914-21. PubMed ID: 20831478
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of varying serum glucose levels on 18F-FDG biodistribution.
    Webb RL; Landau E; Klein D; DiPoce J; Volkin D; Belman J; Voutsinas N; Brenner A
    Nucl Med Commun; 2015 Jul; 36(7):717-21. PubMed ID: 25888357
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 18F-FDG-PET/CT in fever of unknown origin: clinical value.
    Buch-Olsen KM; Andersen RV; Hess S; Braad PE; Schifter S
    Nucl Med Commun; 2014 Sep; 35(9):955-60. PubMed ID: 24801131
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of large-vessel involvement in giant cell arteritis with 18F-FDG PET: introducing an ROC-analysis-based cutoff ratio.
    Hautzel H; Sander O; Heinzel A; Schneider M; Müller HW
    J Nucl Med; 2008 Jul; 49(7):1107-13. PubMed ID: 18552151
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility of Preoperative FDG PET/CT Total Hepatic Glycolysis in the Remnant Liver for the Prediction of Postoperative Liver Function.
    Cho A; Chung YE; Choi JS; Kim KS; Choi GH; Park YN; Kim MJ
    AJR Am J Roentgenol; 2017 Mar; 208(3):624-631. PubMed ID: 28026972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Operational lumped constant for FDG in normal adult male rats.
    Tokugawa J; Ravasi L; Nakayama T; Schmidt KC; Sokoloff L
    J Nucl Med; 2007 Jan; 48(1):94-9. PubMed ID: 17204704
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD; Carlson ER; Heidel RE
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis measured by 18F-FDG PET/CT in salivary gland carcinomas.
    Ryu IS; Kim JS; Roh JL; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    J Nucl Med; 2013 Jul; 54(7):1032-8. PubMed ID: 23670902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of reversible trapping of tracer and the presence of blood metabolites on measurements of myocardial glucose utilization performed by PET and 18F-fluorodeoxyglucose using the Patlak method.
    Herrero P; Dence CS; Sharp TL; Welch MJ; Gropler RJ
    Nucl Med Biol; 2004 Oct; 31(7):883-92. PubMed ID: 15464390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Shortened PET data acquisition protocol for the quantification of 18F-FDG kinetics.
    Strauss LG; Dimitrakopoulou-Strauss A; Haberkorn U
    J Nucl Med; 2003 Dec; 44(12):1933-9. PubMed ID: 14660719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies.
    Reinhardt MJ; Strunk H; Gerhardt T; Roedel R; Jaeger U; Bucerius J; Sauerbruch T; Biersack HJ; Dumoulin FL
    J Nucl Med; 2005 Jul; 46(7):1158-63. PubMed ID: 16000285
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
    Vitale GD; deKemp RA; Ruddy TD; Williams K; Beanlands RS
    J Nucl Med; 2001 Dec; 42(12):1730-6. PubMed ID: 11752067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatic steatosis is associated with increased hepatic FDG uptake.
    Keramida G; Potts J; Bush J; Dizdarevic S; Peters AM
    Eur J Radiol; 2014 May; 83(5):751-5. PubMed ID: 24581596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantification, Variability, and Reproducibility of Basal Skeletal Muscle Glucose Uptake in Healthy Humans Using 18F-FDG PET/CT.
    Gheysens O; Postnov A; Deroose CM; Vandermeulen C; de Hoon J; Declercq R; Dennie J; Mixson L; De Lepeleire I; Van Laere K; Klimas M; Chakravarthy MV
    J Nucl Med; 2015 Oct; 56(10):1520-6. PubMed ID: 26229142
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 18F-FDG PET/CT delayed images after diuretic for restaging invasive bladder cancer.
    Anjos DA; Etchebehere EC; Ramos CD; Santos AO; Albertotti C; Camargo EE
    J Nucl Med; 2007 May; 48(5):764-70. PubMed ID: 17475965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.